Evidence map›Paper›PMID 36350524›Full record

ReviewJapanese journal of radiology2023

Artificial intelligence in lung cancer: current applications and perspectives.

Guillaume Chassagnon, Constance De Margerie-Mellon, Maria Vakalopoulou, Rafael Marini, Trieu-Nghi Hoang-Thi, Marie-Pierre Revel, Philippe Soyer

Abstract readReview
In one paragraph

Review in Japanese journal of radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Artificial Intelligence in the Training of Radiology Residents: a Multicenter Randomized Controlled Trial.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Artificial Intelligence in Medicine.Thoracic research and practice · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guillaume ChassagnonDepartment of Radiology, Hôpital Cochin, AP-HP, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France. guillaume.chassagnon@aphp.fr.
Constance De Margerie-MellonFaculté de Médecine, Université Paris Cité, 75006, Paris, France.
Maria VakalopoulouCentraleSupélec, Mathématiques et Informatique pour la Complexité et les Systèmes, Université Paris-Saclay, 3 Rue Joliot Curie, 91190, Gif-Sur-Yvette, France.
Rafael MariniTheraPanacea, 7 bis boulevard Bourdon, 75004, Paris, France.
Trieu-Nghi Hoang-ThiDepartment of Diagnostic Imaging, Vinmec Central Park Hospital, Ho Chi Minh City, Vietnam.
Marie-Pierre RevelDepartment of Radiology, Hôpital Cochin, AP-HP, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.
Philippe SoyerDepartment of Radiology, Hôpital Cochin, AP-HP, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.ORCID http://orcid.org/0000-0002-5055-1682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) has been a very active research topic over the last years and thoracic imaging has particularly benefited from the development of AI and in particular deep learning. We have now entered a phase of adopting AI into clinical practice. The objective of this article was to review the current applications and perspectives of AI in thoracic oncology. For pulmonary nodule detection, computer-aided detection (CADe) tools have been commercially available since the early 2000s. The more recent rise of deep learning and the availability of large annotated lung nodule datasets have allowed the development of new CADe tools with fewer false-positive results per examination. Classical machine learning and deep-learning methods were also used for pulmonary nodule segmentation allowing nodule volumetry and pulmonary nodule characterization. For pulmonary nodule characterization, radiomics and deep-learning approaches were used. Data from the National Lung Cancer Screening Trial (NLST) allowed the development of several computer-aided diagnostic (CADx) tools for diagnosing lung cancer on chest computed tomography. Finally, AI has been used as a means to perform virtual biopsies and to predict response to treatment or survival. Thus, many detection, characterization and stratification tools have been proposed, some of which are commercially available.

Indexed as

Deep LearningLung NeoplasmsArtificial IntelligenceEarly Detection of CancerHumansTomography, X-Ray ComputedArtificial intelligenceDeep learningDiagnostic imagingLung neoplasmsMultidetector computed tomography

Identifiers

PMID36350524
PMCPMC9643917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.